MCL coexpression mm9:208

Phase1 CAGE Peaks

	Short description
Mm9::chr10:17954736..17954814,-	p1@Ccdc28a
Mm9::chr11:30549453..30549470,-	p3@Acyp2
Mm9::chr11:30549485..30549498,-	p4@Acyp2
Mm9::chr11:30549510..30549523,-	p5@Acyp2
Mm9::chr11:54117682..54117738,+	p2@Acsl6
Mm9::chr11:69476127..69476138,-	p2@Mpdu1
Mm9::chr12:29435230..29435283,-	p1@Ttc15
Mm9::chr12:4082575..4082594,+	p2@Dnajc27
Mm9::chr12:4082596..4082638,+	p1@Dnajc27
Mm9::chr12:71008869..71008876,+	p@chr12:71008869..71008876 +
Mm9::chr12:73862116..73862127,+	p3@Ppm1a
Mm9::chr13:41345116..41345137,+	p5@BC024659
Mm9::chr14:14793700..14793713,-	p4@Thoc7
Mm9::chr15:76077268..76077286,+	p3@Grina
Mm9::chr15:79763014..79763095,-	p2@Cbx7
Mm9::chr15:89284599..89284648,+	p2@Mapk8ip2
Mm9::chr16:44139372..44139396,-	p5@Atp6v1a
Mm9::chr17:22218258..22218274,-	p@chr17:22218258..22218274 -
Mm9::chr17:23908457..23908466,-	p4@Flywch1
Mm9::chr17:23908472..23908504,-	p2@Flywch1
Mm9::chr17:23908510..23908562,-	p1@Flywch1
Mm9::chr17:47832120..47832153,+	p1@Frs3
Mm9::chr18:5592429..5592467,-	p1@Gm10125
Mm9::chr19:45635059..45635134,+	p1@Dpcd
Mm9::chr19:59018084..59018138,-	p3@Hspa12a
Mm9::chr1:193541759..193541783,+	p5@Lpgat1
Mm9::chr1:37356704..37356715,+	p2@Inpp4a
Mm9::chr1:75233073..75233096,+	p3@Dnajb2
Mm9::chr2:120676105..120676123,-	p1@Ttbk2
Mm9::chr2:120676125..120676153,-	p2@Ttbk2
Mm9::chr2:31101562..31101575,+	p4@Ncs1
Mm9::chr2:91550742..91550755,-	p2@Atg13
Mm9::chr3:107499263..107499266,-	p4@Ahcyl1
Mm9::chr3:36512292..36512319,-	p1@Bbs7
Mm9::chr4:149148347..149148388,-	p2@Slc25a33
Mm9::chr5:18732720..18732808,+	p1@Magi2
Mm9::chr6:71781420..71781431,+	p2@Immt
Mm9::chr6:91106734..91106759,+	p3@Hdac11
Mm9::chr8:119467287..119467324,+	p1@Atmin
Mm9::chr8:13890233..13890300,-	p1@2410022L05Rik
Mm9::chr8:73891395..73891439,+	p4@Use1
Mm9::chrX:160346914..160346925,+	p3@Ap1s2
Mm9::chrX:165758314..165758352,+	p1@uc009uxy.1
Mm9::chrX:9240076..9240096,-	p2@Dynlt3

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:

---

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

---

Cell Type

Ontology term	p-value	n
ectodermal cell	7.12e-14	44
neurectodermal cell	7.12e-14	44
neural cell	1.27e-13	43
neuron	9.50e-13	33
neuronal stem cell	9.50e-13	33
neuroblast	9.50e-13	33
electrically signaling cell	9.50e-13	33
non-terminally differentiated cell	2.47e-12	49
CNS neuron (sensu Vertebrata)	4.13e-12	23
neuroblast (sensu Vertebrata)	4.13e-12	23
electrically responsive cell	3.40e-11	39
electrically active cell	3.40e-11	39

Uber Anatomy

Ontology term	p-value	n
central nervous system	1.76e-31	73
nervous system	6.81e-31	75
ectoderm-derived structure	3.24e-30	95
ectoderm	3.24e-30	95
presumptive ectoderm	3.24e-30	95
neurectoderm	5.98e-29	64
neural plate	5.98e-29	64
presumptive neural plate	5.98e-29	64
regional part of nervous system	7.65e-27	54
structure with developmental contribution from neural crest	8.68e-27	92
neural tube	2.57e-25	52
neural rod	2.57e-25	52
future spinal cord	2.57e-25	52
neural keel	2.57e-25	52
ecto-epithelium	5.33e-25	73
brain	3.06e-22	47
future brain	3.06e-22	47
pre-chordal neural plate	3.81e-22	49
regional part of brain	1.17e-21	46
anterior neural tube	8.73e-19	40
regional part of forebrain	4.05e-18	39
forebrain	4.05e-18	39
future forebrain	4.05e-18	39
gray matter	9.23e-18	34
brain grey matter	4.61e-15	29
regional part of telencephalon	4.61e-15	29
telencephalon	4.61e-15	29
cerebral cortex	1.29e-10	21
cerebral hemisphere	1.29e-10	21
pallium	1.29e-10	21
regional part of cerebral cortex	2.10e-09	17
anatomical conduit	2.14e-09	122
tube	3.67e-09	114
multi-cellular organism	1.14e-07	333
posterior neural tube	4.32e-07	12
chordal neural plate	4.32e-07	12
occipital lobe	7.09e-07	10
visual cortex	7.09e-07	10
neocortex	7.09e-07	10

TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}